General Information

All
  • All
  • Ongoing
  • Completed
Apr 13 @ 12:00 pm

ATTeST

This trial assessed the safety and efficacy of the EryDex System to treat neurological symptoms associated with A-T.

more
Apr 13 @ 12:00 pm

Baclofen Study

At the dose tested, Baclofen did not have a significant effect on tremor, eye movement or balance deficits.

more
Apr 13 @ 12:00 pm

Betamethasone Trials

These trials studied whether a low dose betamethasone would reduce neurological symptoms associated with A-T.

more
Apr 13 @ 12:00 pm

Cerebrospinal Fluid Biomarker Study

Among the 204 identified CSF proteins, 13 showed significant changes in A-T patients versus control samples.

more
Apr 13 @ 12:00 pm

Dexamethasone Trial

This open label study was performed to assess the safety and tolerability of the EryDex System in people with A-T.

more
Apr 13 @ 12:00 pm

Effect of Amantadine on Movement Disorder in A-T

This trial was performed to see if amantadine sulphate improves ataxia or other movement disorders associated with A-T.

more
Apr 13 @ 12:00 pm

Global A-T Family Data Platform

The Platform is a patient-driven effort through which data about people with A-T are shared with researchers.

more
Apr 13 @ 12:00 pm

IB1001 TRIAL

IntraBio, Inc. is studying the effects of N-Acetyl-L-Leucine on A-T.

more
Apr 13 @ 12:00 pm

Inositol Treatment Trial

This study aimed to determine if inositol has therapeutic benefit for total lymphocyte count or ataxia.

more
Apr 13 @ 12:00 pm

L-Dopa Treatment Trial

No overall consistent improvement in neurologic function was observed on L-Dopa.

more
Apr 13 @ 12:00 pm

Machine Vision and Learning for A-T Neurophenotypes

This study seeks to develop sensitive, automated and objective means of measuring neurological disease severity.

more
Apr 13 @ 12:00 pm

Nicotinamide Riboside (Niagen) Proof-of-concept Study

This trial in the Netherlands looked at the effects of nicotinamide ribose as a potential treatment for people with A-T.

more